Intrinsic Value of S&P & Nasdaq Contact Us

Amphastar Pharmaceuticals, Inc. AMPH NASDAQ

NASDAQ Global Select • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score
71/100
4/7 Pass
SharesGrow Intrinsic Value
$35.53
+66.2%
Analyst Price Target
$30.00
+40.3%

Stock Statistics — AMPH

Amphastar Pharmaceuticals, Inc. (AMPH) has a market capitalization of $982.46M and trades at $21.38. The 52-week range is 17.03-31.26.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 10.2, Earnings Per Share (EPS) of $2.10, annual revenue of $719.89M.

The stock has a beta of 0.91, operates in the Healthcare sector.

Trading Data
Current Price$21.38
52-Week Range17.03-31.26
Volume329.79K
Avg Volume (30D)498.04K
Market Cap$982.46M
Beta (1Y)0.91
Company
IPO Date2014-06-25
Employees2,028
CEOYongfeng Zhang
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS03209R1032
CUSIP03209R103
Income (Latest Year)
Revenue$719.89M
Gross Profit$356.06M
EBITDA$149.11M
Operating Income$140.4M
Net Income$98.09M
EPS$2.10
EPS Diluted$2.03
Shares Outstanding$46.74M
Balance Sheet (Latest Year)
Total Assets$1.63B
Current Assets$636.02M
Cash & ST Investments$282.81M
Total Liabilities$840.49M
Total Debt$656M
Net Debt$485.83M
Total Equity$788.81M
Debt / Equity0.83
Valuation Ratios
P/E Ratio10.2
P/S Ratio1.36
P/B Ratio1.25
EV/EBITDA (approx)6.6
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message